Regulation of Fibroblasts and Fibrosis in Cardiovascular Disease

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cells of the Cardiovascular System".

Deadline for manuscript submissions: 20 August 2024 | Viewed by 74

Special Issue Editor


E-Mail Website
Guest Editor
Department of Cell Biology and Anatomy, University of South Carolina School of Medicine, Columbia, SC 29209, USA
Interests: fibrosis; extracellular matrix; fibroblast activation; integrins; cardiovascular disease; alcohol abuse; decellularization; tissue engineering
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The extracellular matrix forms a three-dimensional network of fibrous proteins and other biopolymers surrounding cells. Contrary to previous views, it is now appreciated that the extracellular matrix is highly dynamic, with alterations in composition and organization to meet the mechanical demands of tissues and organs. An increased deposition of the extracellular matrix is a common, transient response to tissue damage or stress in many organs. Dysregulation of the repair process can result in chronic increases in extracellular matrix or fibrosis. Accumulation of the extracellular matrix results in altered tissue biomechanical properties and can deleteriously impact tissue and organ function. In the cardiovascular system, fibrosis is a predictor of adverse cardiovascular events and is an important driving force in the progression of cardiovascular disease.   Fibrosis is a highly complex process that involves a number of cell types, including extracellular matrix-producing cells, as well as immune and inflammatory cells. This process also involves an array of biochemical mediators, including secreted factors and diverse signaling pathways. Recent studies in experimental models and clinical observations indicate that fibrosis may be reversible. This has led to enhanced interest in elucidating the underlying mechanisms of fibrosis and identifying novel therapeutic targets for this process.

This Special Issue aims to provide review and primary research articles focused on the cellular and molecular mechanisms of cardiovascular fibrosis and potential therapeutic approaches for this processes.

We look forward to your contributions to this exciting Special Issue of Cells.

Prof. Dr. Wayne Carver
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • fibrosis
  • fibroblasts
  • cardiovascular
  • inflammation
  • extracellular matrix
  • collagen

Published Papers

This special issue is now open for submission.
Back to TopTop